All posts by medical

Will Andrew DeLuca Be The Next Doctor To Leave Greys Anatomy? – Refinery29

Why? Well, it has to do with Greys latest episode, in which the surgeon hiked six miles in the snow to get a liver for a young patient. While thats certainly heroic, the fact that he wasnt wearing gloves might have ended his career, since he returned to the hospital with severe frostbite on his hands.

See the original post:
Will Andrew DeLuca Be The Next Doctor To Leave Greys Anatomy? - Refinery29

The Most Heartbreaking Deaths On Greys Anatomy,’ Ranked – Pulse Live Kenya

BusinessInsider USA Images

16. Heather Brooks Heather was a surgical intern during seasons 9 and 10. Following a superstorm, she found Dr. Webber suffering from an electrical shock in the generator room. While trying to help him, she stepped in an electrified puddle herself, causing her to slip and hit her head. She died from brain swelling. Ron Tom

BusinessInsider USA Images

15. Dr. Craig Thomas Dr. Thomas worked at the Mayo Clinic, and mentored Cristina during her boards. Due to his old age, he suffered a heart attack while in the operating room. ABC

BusinessInsider USA Images

14. Henry Burton Henry was a former pro baseball player who worked as a shipping clerk, and when he came to the hospital with Von-Hippel-Lindau syndrome without insurance, surgical resident Teddy Altman proposed that they get married so he could be on her insurance. After several surgeries and a diabetes diagnoses, a CT scan revealed a tumor near his heart. Cristina and Dr. Webber immediately operated on his heart, but he died during surgery because the tumor eroded his pulmonary artery. Adam Taylor

BusinessInsider USA Images

13. Charles Percy Charles was a surgical resident at Sloan Memorial who was tragically murdered when the husband of a deceased patient became an active shooter looking to murder the surgeons who operated on his wife. When the shooter asked Charles if he was a surgeon and Charles said yes, he got shot. His death was particularly tragic because on his deathbed, he told Bailey to tell Reed (who also died during the shooting) that he loved her. Eric McCandless

BusinessInsider USA Images

12. Reed Adamson Reed was also murdered by widower-slash-shooter Gary Clark, who asked her to help him find Derek Shepherd, which she refused. He shot her in the head, and her best friend and roommate April Kepner slipped in a puddle of her blood. Ron Tom

BusinessInsider USA Images

11. Susan Grey Susan Grey was Meredith's stepmother, and the mother of Lexie and Molly Grey. She first arrived at the hospital complaining of hiccups and acid reflux, and after being sent home twice, she returned with a fever and cramping and went into surgery. She died after surgery after suffering sepsis and a toxic megacolon, and Meredith's father blamed Meredith for Susan's death. Vivian Zink

BusinessInsider USA Images

10. Dylan Young Dylan was in charge of the Seattle Police Department Bomb Squad during the bomb scare that panicked Sloan Memorial Hospital during season 2, episode 17. (A World War II fanatic built a bazooka in his backyard and then became impaled with the explosive, which endangered the hospital because there was literally a bomb inside of him.) After Meredith successfully removed the explosive from inside the patient's chest, she handed it to Dylan, and it exploded, killing him. Peter "Hopper" Stone

BusinessInsider USA Images

Doc the Dog Meredith adopted Doc to help her get over Derek after he got back together with Addison (played by Kate Walsh). But when Meredith discovered Doc had bone cancer, she decided to put him to sleep. And well, it's one of the saddest Grey's death scenes...even if it is about a dog. ABC

BusinessInsider USA Images

8. Adele Webber Adele (played by Loretta Devine) suffered from Alzheimer's. While she died offscreen, it was the scene where Richard (James Pickens Jr.) operated on her and sang "My Funny Valentine" (leading her to believe it was their wedding night) that had everyone a complete mess. Kelsey McNeal - Getty Images

BusinessInsider USA Images

7. Ellis Grey Ellis (Kate Burton) wasn't exactly an all-star mother to Meredith, but her death, also from Alzheimers, rocked Meredith's world. Fans did see Meredith get a bit of closure, however, when she nearly drowned and saw her mother. In that episode, Ellis tells Meredith she's anything but ordinary and that she needs to stay alive. It's a mother-daughter moment only Grey's could pull off. Michael Desmond - Getty Images

BusinessInsider USA Images

6. Samuel Norbert Avery When Jackson Avery (played by Jesse Williams) and April (Sarah Drew) had a baby, it seemed like a moment to rejoice. But viewers quickly the infant had a life-threatening diseaseand he died shortly after birth. Eric McCandless - Getty Images

BusinessInsider USA Images

5. Mark Sloan McSteamy (played by Eric Dane) died after Lexie as a result of injuries he sustained in a plane crash they were both in. Because Mark's will stated he wanted to remain on life support for 30 days before being taken off of it, fans had to wait through the summer hiatus to learn his fate. Jean Baptiste Lacroix - Getty Images

BusinessInsider USA Images

4. Denny Duquette This one nearly broke us. The prospects for Denny (Jeffrey Dean Morgan) were always grim, given that viewers first met him because he was admitted to the hospital for heart failure. But Izzie Stevens (Katherine Heigl) fell for him anyway, and when he died in her arms, fans mourned right alongside her. Denny did, however, return in ghost formtwice. Once when Meredith nearly drowned, and again when Izzie was was being treated for Stage 4 cancer. Scott Garfield - Getty Images

BusinessInsider USA Images

3. Lexie Grey Not only was Lexie (played by Chyler Leigh) crushed to a death by a a piece of shrapnel from the tragic airplane crash she and Mark were in together, but she took her last breath as Mark admitted his love for her: "Ive always loved you, Ill always be in love with you." I'm not crying, you're crying. Randy Holmes - Getty Images

BusinessInsider USA Images

2. George OMalley The death of George (played by actor T.R. Knight) was one of the worst to witness, perhaps because it was so sudden. After pushing a woman out of the way to avoid an oncoming bus, George ended up getting hit by the bus himself. His injuries were so severe that he was unrecognizablethat is, until he traced "007" (his nickname) on Meredith's hand. He ultimately died, and fans would never be the same. Scott Garfield - Getty Images

BusinessInsider USA Images

1. Derek Shepherd This was the saddest Grey's death of all because I really thought it was the one happily ever after Shonda might let one of her characters have. But when Derek (Patrick Dempsey) suffered brain damage from a tragic accident, we watched Meredith say goodbye to McDreamy. Before she gave the go-ahead to take him off life support, Meredith said, "Derek, it's okayyou go. I'll be fine." Years later, and fans still aren't okay. Are you sobbing yet? Because I sure as hell am. Scott Garfield - Getty Images

Link:
The Most Heartbreaking Deaths On Greys Anatomy,' Ranked - Pulse Live Kenya

How Cardiorespiratory Function Is Related to Genetics – Sleep Review

How high altitudes affect peoples breathing and its coordination with the heart beat is due to genetic differences, say researchers.

Clear physiological differences have already been demonstrated between people living in the Himalayas and Andes compared with people living at sea level, revealing an evolutionary adaptation in the control of blood flow and oxygen delivery to the brain and the rest of the body.

Now an international team led by Aneta Stefanovska, PhD, a professor at Lancaster University has identified genes that are related to cardiorespiratory function during so-called acute periodic breathing. Their report is published in the Journal of Physiology.

Periodic breathing (PB) occurs in most humans at high altitudes and is characterized by periodic alternations between hyperventilation (too-fast breathing) and apnea (no breathing). The altered respiratory pattern due to periodic breathing is accompanied by changes in heart rate and blood flow.

Breathing, ECG of the heart, and microvascular blood flow were simultaneously monitored for 30 minutes in 22 healthy male subjects, with the same measurements repeated under normal and low oxygen levels, both at real and simulated altitudes of up to 3800m.

As part of the experiment, the participants were also taken in a cable car to a high altitude laboratory at the top of Aiguille du Midi mountain in Chamonix in France and tested immediately on arrival and after six hours at this altitude of 3842m.

The researchers found that orchestration between the participants hearts and lungs, as measured by phase coherence, responded differently to periodic breathing depending on whether they had one of two specific genetic variants affecting the cardiorespiratory response to insufficient oxygen.

Chronic periodic breathing is generally seen as an unfavorable state, being associated with increased mortality in chronic heart failure, but in healthy people it may be an indication of better alertness to oxygen insufficiency at high altitudes.

Hypoxia, as well occurring during rapid ascents to high-altitudes, can also be a significant problem at sea-level, being a contributory factor in many health conditions including cancer, strokes, and heart attacks.

Stefanovska says in a release, The similarities between hypoxia-induced PB at altitude, and the breathing characteristics observed in certain pathological states, provide an opportunity to further our understanding of the physiological processes involved in chronic hypoxic states that occur even when oxygen is abundant.

Considering living systems as collections of interacting oscillators whose dynamics is governed by multiple underlying open systems enables the observation of functional changes over time, and investigation of how they are altered in health and disease.

Image: Participants were also taken in a cable car to a high altitude laboratory at the top of Aiguille du Midi mountain in Chamonix in France. Credit: Lancaster University

See the original post:
How Cardiorespiratory Function Is Related to Genetics - Sleep Review

Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week’s Release – Zacks.com

Signal Genetics, Inc. (MGEN - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 11. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus Estimate

This company is expected to post quarterly loss of $0.25 per share in its upcoming report, which represents a year-over-year change of +24.2%.

Revenues are expected to be $0.97 million, up 102.1% from the year-ago quarter.

Estimate Revisions Trend

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings Whisper

Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Signal Genetics, Inc.

For Signal Genetics, Inc.The Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Signal Genetics, Inc. Will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?

While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Signal Genetics, Inc. Would post a loss of $0.30 per share when it actually produced a loss of $0.36, delivering a surprise of -20%.

Over the last four quarters, the company has beaten consensus EPS estimates just once.

Bottom Line

An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Signal Genetics, Inc. Doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

See original here:
Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Zacks.com

When Tough Weather Hits Crops, Modern Genetics Helps Them Perform – Hoosier Ag Today

Amazing-modern-genetics

Will the 2020 crop season shape up like last year? It would be quite a stretch to think the elements could stoop to that level a second year in a row.

Ive been in the industry 35 years and my dad is 86, says John Kermicle, Brand Manager for AgriGold. He kept comparing last year to other years and finally said, John, there hasnt been any other year like 2019. So, it was the worst.

Kermicle was in Texas last week at the companys Commodity Classic trade show booth. He told HAT the advances in seed and seed treatments continue to benefit farmers in good conditions and bad.

In general, corn yields were pretty good again, he said. Some areas were off, but truly todays genetics with the treatments that we have today, its not like the 1980s or early 2000s. They can handle an amazing amount of weather and still do pretty well.

In presentations at the AgriGold booth, Kermicle touted their customers success in the most recent corn yield contest. The contest, he says, is another important tool for corn growers.

We want to help growers grow more corn. Thats why were in business. So, the contest really helps growers think outside the box, and then how can we take these learnings and apply it across whole farm operations? Thats kind of our approach.

He says there are several new products in the 2020 lineup.

We have a really strong research program and the first time we see some of our products are as conventionals. Were introducing eight new conventionals that will then have traits a year of two after that.

Learn more at http://agrigold.com/.

Read more from the original source:
When Tough Weather Hits Crops, Modern Genetics Helps Them Perform - Hoosier Ag Today

Sarah Elsea, PhD, FACMG Is Elected to the Board of Directors of the ACMG Foundation for Genetic and Genomic Medicine – BioSpace

BETHESDA, Md., March 4, 2020 /PRNewswire/ --Sarah H. Elsea, PhD, FACMG, professor of molecular and human genetics at Baylor College of Medicine and senior director of biochemical genetics at Baylor Genetics, has been elected to the board of directors of the ACMG Foundation for Genetic and Genomic Medicine.The ACMG Foundationis a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice. The board members are active participants, serving as advocates for the Foundation and for advancing its policies and programs. Dr. Elsea was elected to a two-year term starting immediately.

"It is our pleasure to welcome Dr. Sarah Elsea to the ACMG Foundation Board of Directors. Dr. Elsea's experience in medical genetics and commitment to the mission of the College will add greatly to our ability to support clinical and educational activities on behalf of our members and the public," said ACMG Foundation President Bruce R. Korf, MD, PhD, FACMG.

Dr. Elsea received a Bachelor of Science in Chemistry with a minor in biology from Missouri State University and a PhD in biochemistry from Vanderbilt University. She completed postdoctoral fellowships in molecular and biochemical genetics at Baylor College of Medicine and is board certified by the American Board of Medical Genetics and Genomics.She held faculty appointments at Michigan State University and the Medical College of Virginia at Virginia Commonwealth University prior to returning to Baylor College of Medicine in 2013. Her research is focused on the discovery, pathomechanisms, diagnosis and treatment of rare and complex disease, particularly neurodevelopmental and metabolic disorders that involve sleep disturbance, behavioral phenotypes, obesity and cancer. While most of the work in Dr. Elsea's lab has a molecular basis, her work with children and families living with Smith-Magenis syndrome and other neurodevelopmental disorders has focused several studies toward the family, sibling and caregiver experience for those caring for and living with individuals with complex neurodevelopmental conditions. Her primary goals have focused toward supporting education and research to develop appropriate interventions to improve the health and quality of life of persons with neurodevelopmental and metabolic disorders using an integrated approach to education, outreach and mentoring. Dr. Elsea works collaboratively with support groups to develop relevant, targeted research to inform and improve upon quality of life for individuals affected by genetic conditions. Dr. Elsea serves on the board of directors of the American Board of Medical Genetics and Genomics and is chair of the Parents and Researchers Interested in Smith-Magenis Syndrome (PRISMS) Professional Advisory Board.

About being elected to the ACMG Foundation Board of Directors, Dr. Elsea said, "As we focus toward defining targeted treatments for both rare and common disease, we have an increasing need to translate genetics in healthcare.The mission of the Foundation to support and foster the training and education of medical geneticists and to enhance community education and awareness of genetics and genomics is at the heart of my work. I am both honored and delighted for the opportunity to support the ACMG Foundation Board of Directors, and I look forward to working with the Foundation to advance these goals."

A complete roster of the ACMG Foundation board can be found at http://www.acmgfoundation.org.

About the ACMG Foundation for Genetic and Genomic Medicine

The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation supports the American College of Medical Genetics and Genomics (ACMG) mission to "translate genes into health." Through its work, the ACMG Foundation fosters charitable giving, promotes training opportunities to attract future medical geneticists and genetic counselors to the field, shares information about medical genetics and genomics, and sponsors important research. To learn more and support the ACMG Foundation mission to create "Better Health through Genetics" visit acmgfoundation.org.

Kathy Moran, MBAkmoran@acmg.net

View original content to download multimedia:http://www.prnewswire.com/news-releases/sarah-elsea-phd-facmg-is-elected-to-the-board-of-directors-of-the-acmg-foundation-for-genetic-and-genomic-medicine-301015856.html

SOURCE American College of Medical Genetics and Genomics

Go here to see the original:
Sarah Elsea, PhD, FACMG Is Elected to the Board of Directors of the ACMG Foundation for Genetic and Genomic Medicine - BioSpace

Demand for Well-bred Animals With Desirable Genetic Traits to Drive Animal Genetics Market: Transparency Market Research – PRNewswire

ALBANY, New York, March 4, 2020 /PRNewswire/ -- Owing to multiple factors such as adoption of advanced technologies, high demand for well-bred animals with desirable genetic traits (livestock and poultry), and increase in disposable income is helping the global animal genetics marketchart a Compound Annual Growth Rate of 6.0 % from 2018 to 2026. As a result of this robust growth rate, market would be reach a valuation of USD 8.0 bn by the end of the forecast period.

Transparency Market Research states, "One of the most significant trends that will lead to a higher market growth over the forecast period is increase in ownership of companion animals. Besides, with food safety and quality gaining prominence, the live animal segment will show significant growth from 2018 to 2026."

Key Findings of the Animal Genetics Market Study

Explore 157 pages of top-notch research, incisive insights, and detailed country-level projections. Gain business intelligence on Animal Genetics market by Product Type - Live Animals (Bovine, Porcine, Poultry, Canine, and Piscine), Genetic Material (Semen, Embryo), Genetic Testing, Read Details TOC of the Report - https://www.transparencymarketresearch.com/report-toc/18995

Animal Genetics Market: Key Driving Factors

The animal genetics market is set to witness sturdy growth over the forecast period owing to a plethora of trends and growth drivers. As per Transparency Market Research, some of the crucial factors are high level of consumption of meat and poultry products, increase in purchasing power of people, need to plug supply gaps in terms of food, and growing demand for stronger animals, well-bred and with desirable genetic traits. An overview of growth factors is provided below:

Request PDF Brochure of Animal Genetics Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18995

Key Impediments for Animal Genetics Market Players

Despite charting a steady growth curve over the forecast period, the global animal genetics market would not be free from restraints. As per Transparency Market Research, one of the major restraints that will limit growth in the global animal genetics market is the regulatory environment which is strict in terms of animal genetic engineering. Besides, a notable dearth of skilled professionals in the market is also a limiting factor in the global animal genetics market. Additionally, it is worth noting that animal testing is expensive.

Animal Genetics Market: Region-wise Analysis

Analyze Animal Genetics market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sampleof the study,

Competition Landscape

Research and Development (R&D) forms the core of global animal genetics market and is thus a major determinant of the size of market share a player holds. Besides, players also forge partnerships in order to tap into uncharted territories in order to bring a larger consumer base into the fold. It is pertinent to note here that technology also holds a prominent place in the market.

Transparency Market Research has profiled key players such as Genus plc, CRV Holding B.V., Neogen Corporation Zoetis, Inc., Groupe Grimaud, Topigs Norsvin, VetGen, Animal Genetics Inc., and Hendrix Genetics BV, in its market report. The global animal genetics market has a decent number of players operating the market landscape.

Transparency Market Research has segmented the Animal Genetics market report based on product type, geography and forecast.

Product Type:

Explore Transparency Market Research's award-winning coverage of the Global Healthcare Industry:

Thyroid Function Test Market: The global thyroid function test market was valued at approximately US$ 1.3 Bn in 2018. It is anticipated to exceed a value of US$ 2.4 Bn by 2027, expanding at a CAGR of more than 5% from 2019 to 2027. The global market is driven by an increase in the incidence of thyroid disease, rise in geriatric population, increase in obese, diabetic, and cardiovascular patients, and increase in disease awareness programs in developing regions.

DNA Test Kits Market: The global DNA test kits market is driven by increase in the number of direct to consumer genetic testing companies offering DNA tests for ancestry and health & fitness, rise in focus on health risk & preventive care, and increase in demand for ancestry DNA testing services across the globe.

Audiological Devices Market: The global audiological devices market was valued at about US$ 8.7 Bn in 2017 and is expected to reach a value of US$ 13.4 Bn by 2026, expanding at a compound annual growth rate (CAGR) of over 5.0% from 2018 to 2026. The global market is witnessing expansion at a relatively higher growth rate owing to the increasing geriatric population, adoption of audiological devices due to rising number of cases of hearing loss, and surge in research and development in both developed and developing markets.

Laser Capture Microdissection Market: Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key tohelp enterprises reach right decision."

Contact

Transparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: [emailprotected]

Website: http://www.transparencymarketresearch.com

SOURCE Transparency Market Research

Continued here:
Demand for Well-bred Animals With Desirable Genetic Traits to Drive Animal Genetics Market: Transparency Market Research - PRNewswire

What Neuroscience Can Tell Us About Nutrition – Thrive Global

Extreme obesity can knock eight years off your life, according to one Canadian study. But even being overweight has a clear impact on how we age. One study found that obese people had substantially less white matter in their brains than leaner people. While our brains naturally shrink with age, the brains of the obese people were found to have a comparable white matter volume to a lean person 10 years their senior. The impact on cognitive function is not known, but its unlikely to be good.

Obesity is the main cause of type 2 diabetes, which is most prevalent in older people. The number of Brits with type 2 diabetes has doubled in 20 years and it now accounts for almost 9 per cent of the annual NHS budget. A third of Americans over 65 now have type 2 diabetes. The consequences can be really nasty: blurred vision, sores which wont heal, even toe, foot and leg amputations.

Type 2 diabetes develops when our bodies consume so many carbohydrates that the pancreas ceases to release the right amounts of the hormone insulin into the blood, to regulate the glucose that gives us energy. Our systems are overwhelmed and they fail.

People who head into their sixties obese are storing up real trouble in Extra Time. Doctors are wary of interfering, because they feel that what we eat is a lifestyle choice. Personally, Im not so sure how much of a choice it is. Public health agencies have spent decades exhorting people to lose weight with almost no effect. I have become convinced that one reason we find it so hard to lose weight is that junk foodespecially sugaris addictive.

When I served on the board of the Care Quality Commission, the national regulator for hospitals, the scourge of obesity was every-where. Hospitals were having to reinforce beds for super-sized patients. Doctors were refusing knee replacements to people who were so overweight they feared the replacements would buckle under the strain. Some of those people became less active because their joints hurt and so gained even more weight. It was a terrible vicious cycle.

Around the same time I watched a talk by the American paediatric endocrinologist Professor Robert Lustig. He argues that sugar is the main cause of obesity, because sugar is as addictive as nicotine and switches on the same hormonal pathways which reward behaviour. Low blood sugar affects mood, concentration and the ability to inhibit impulse. Eating or drinking something sugary reverses the effect, but if the pattern is repeated for long enough, it results in insulin resistance, type 2 diabetes, heart disease and obesity. Professor Lustig believes that it is not possible for most people to quit through willpower because that has been eroded by the cycle of craving.

My mothers switch from nicotine to sugar made Lustigs narrative especially compelling for me: she simply replaced one addiction with another. And it chimed with my own experience. Battling exhaustion after my third child, and sitting opposite a fellow columnist who practically mainlined Coca-Cola, I fell into the habit of needing a Coke and chocolate bar before every deadline. Since I was filing copy almost everyday, as a Times leader writer, my consumption of sugar was considerable. And pretty soon the chocolate bar was no longer a single small, elegant Green & Blacks, but a string of Yorkie bars.

This kind of mindless eating has been brought to life, hilariously and poignantly, in experiments by Brian Wansink of Cornell University. In one, he gave stale popcorn to two groups of cinema-goers. One group got big buckets, the other got giant buckets so large that researchers assumed no one would finish them. When the movie ended, the people with giant buckets had scoured them clean theyd consumed 50 per cent more popcorn than the others. When told this, most were astonished.

For decades, we were warned off saturated fat. A profitable industry grew up selling low-fat processed foods. But these are a con. To make them tasty, manufacturers stuff them with carbohydrates and sugar. These create spikes in blood-sugar levels, which lead to cravings when blood sugar falls, along with the brains chemical messenger, dopamine. Dopamine gives pleasure, but also regulates our self-control. So Big Food offering low-fat cakes is the equivalent of Big Tobacco offering low-tar cigarettes: they make us feel better about ourselves, while keeping us hooked.

I hope that doesnt sound hysterical. In 2015, there was a mortifying moment when I was called a health fascist by one of the prime ministers other advisers. We had just come out of his office in Downing Street, where I had been arguing that we should tax sugary drinks. I was taken aback to hear myself described as fascist. But I believed we could no longer rely on exhortation to stem the obesity epidemicwe needed manufacturers to change their ingredients.

In 2016, the UK government announced that it would levy a tax on sugary drinks to tackle obesity. By the time the levy came into force two years later, most brands had already done what we had hoped they would: reformulate to avoid the tax, thus withdrawing substantial amounts of sugar from the supermarket shelves. While a few customers have complained about taste and Coca-Cola has refused to dilute its legendary Classic many are switching to low-sugar products. This suggests that relatively small signals can change markets.

Reformulating food is much more complicated for the obvious reason that processed foods contain far more ingredients than drinks (if you remove all the sugar from a cake, it will simply collapse and look like a souffl). But the UK government has already had some success in working with manufacturers to remove salt from processed foods. The same could be done for sugarwith the right combination of goodwill and political drive.

The assault on cigarettes was only partially about taxing and making them more expensive. It also involved health warnings on packets and restrictions on advertising. We need clear, unequivocal health warning on processed food and drink in a universal language, not complex labels in small print that few of us can make sense ofespecially when were rushing down a supermarket aisle, vulnerable to pester power. One doctor recently told me that the government should be focusing on parents and grandparents, not child obesity. Unless the parents and grandparents lose weight, she said, weve got no chance with the children.

Parents and grandparents may not trust government, or the media, to tell them what to do. But they do trust doctors.

Follow ushereand subscribeherefor all the latest news on how you can keep Thriving.

Stay up to date or catch-up on all our podcasts with Arianna Huffingtonhere.

Read the original post:
What Neuroscience Can Tell Us About Nutrition - Thrive Global

Helmets protect athletes’ skulls. Will the NFL use neuroscience to protect their brains? – Massive Science

As a spectator, its easy to forget the long term consequences of 300 pound humans crashing intoeach other at over 20 miles per hour. But this is the reality of American football. During play, the brain is one of the most susceptible parts of the body and thelong-termdanger may remain hidden until years after retirement.

New safety rules and improved helmets prevent injuries such as skull fractures. But no amount of training or equipment is yet known to prevent concussions, internal brain injuries caused when the brain shakes back and forth, or chronic traumatic encephalopathy (CTE), the neurodegenerative disease that results from accumulated hits to the head. The best thing we can do is stop playing these types of sports. The second best option is to mitigate the risks.

The NFL is plagued with controversy over the league's relationship with head injuries. Traditional helmets are designed to prevent skull fractures. However, concussions are not just blunt force trauma, but results of rotational forces exerted when the head snaps back and forth.

Symptoms of CTE don't appear until years or decades after chronic impacts

Wikimedia Commons

If the NFL wants to get serious about concussion prevention, as many believe they morally have a responsibility to do, independent neuroscience has to have a leading role in how helmets are designed.While the NFL denies bias in how they use science, it is impossible to deny that they have a large financial interest in the results, and this has led to questionable measures on head protection. From 1994 to 2009, the NFL actually employed their own research committee. But the committee was overhauled in 2009 after criticismfrom Congress for their continued denial of the link between football and brain disease.

And then there are equipment companies like Riddell, which was sued by thousands of former NFL players in 2013 for falsely claiming that players using their Revolution helmet were 31 percent less likely to get a concussion. Riddell based their marketing on a study of their new helmet by scientists at the University of Pittsburgh Medical Center. Even when the authors of the paper informed Riddell that their interpretation of their results was wrong (the actual reduction was closer to 2 percent), Riddell failed to alter the original claim.

Sciences approach for the modern American football helmet

If youve ever been a passenger in a car that suddenly slams on its breaks, you know a little of what it's like to be tackled. You probably fall forward, kept in your seat by your seat belt. The car stopped, but you were still rapidly accelerating. You experienced a linear force.Measurements on a college player showed the average acceleration of 10 hits he took during a single game. Each hit was roughly equivalent to what you would feel if you crashed a car into a wall going about 30 miles per hour.

Players' brains are very vulnerable in such a high-impact sport

Photo by Robina Weermeijer on Unsplash

Understanding of concussions and CTE has evolved significantly over the past few years and helmet designs are now just starting to catch up with the research. For example, scientists once thought that a concussion only bruised the outer grey matter surface of the brain.New research published over the past five years demonstrates that the brain doesnt bruise, but does experience rotational forces and damage extending to white matter, deep tissue in the brain, as the fibers in white matter pull and twist upon impact.

Designing a better helmet is about being creative about reducing the rapid deceleration of the brain upon impact. In 2013, the start up company VICIS set out to create a helmet based on this current medical knowledge, with neurosurgeons, concussion specialists, and former NFL team physicians as advisers. Their approach focused on rotational forces on the brain instead of just linear ones.

Thanks to the more than $85 million raised, $1.1 million from the NFL, they launched the ZERO1 helmet in 2016. This product has a reflex layer'' inside the shell composed of dozens of separate columns of padding, which bend, compress, and move in response to force in every direction, whether it's linear or rotational. The helmet also has a deformable'' outer shell that morphs its shape when hit, acting like a car bumper to absorb the blow. Since acceleration is speed divided by time, you can reduce acceleration by either decreasing speed or prolonging the time of the impact. The idea behind the car bumper properties of ZERO1 is that it increases thetime of impact.

In 2018, 120 professional and college teams wore the ZERO1. Performance testing suggests that this collaborative approach between scientists and sports was working. The ZERO1 football helmet was ranked #1 in ability to reduce force to the head in the NFLs and NFL Player Association helmet laboratory performance testing from 2017-2019, every year it has been available.

While this innovative helmet design washailed by neuroscientists, players, and sports leagues alike, VICIS did not survive competition with Schutt and Riddell, the two dominant companies in the helmet industry. In late 2019, VICIS announced it was out of money.

Other scientists are taking up the challenge to build a better helmet. David Camarillo is not just an Assistant Professorat Stanford University, he is also a former college football tight end. In 2013,his research labdeveloped computerized mouth guards to help accurately chart head acceleration data upon head impacts.

Former NFL player Junior Seau died at age 43. The NIH concluded that he suffered from CTE

Wikimedia Commons

While most helmets use solids to absorb energy, like foam or the columns in the VICIS ZERO1, the Camarillo lab'sapproach introduces liquid into thehelmetwith the idea that liquids can absorb more energy than solids. Camarillo compares the design to a hydraulic shock absorber." The team used computer simulations of an NFL impact test and compared the liquid approach with four other helmets with different energy absorption technologies. Results from his study suggest that the helmet reduces the average brain tissue strain upon impact by about 25 percent and could reduce concussions by at least 75 percent. However, as these results are still based entirely on computer simulations, the safety and logistics of building an actual helmet are still in research stages.

A concussion is not the same as CTE

While these new helmets are intended to prevent concussions, singular events caused by one hit, they may still be insufficient to protect against CTE. CTE is a neurodegenerative disease resulting from cumulative hits, whether they are concussive or not, that occur many times over many years. CTE is nearly impossible to study as symptoms almost never occur until many years or decades after repeated head trauma and positive diagnosis is only possible through an autopsy after death.

Ann McKee is a neuropathologist and expert in neurodegenerative diseases. She also directs Boston Universitys CTE Center. Her 2017 paper became famous when it suggested that 99 percent of former NFL players showed pathological evidence of CTE based on data collected from former players whose brains had been donated to Boston brain banks. The paper was scrutinized on the grounds that brains donated for CTE diagnosis may be biased towards CTE presence (i.e. family members saw the signs while the donor was alive). Her 2019 article enhances the correlation by being the first paper to include a non-football playing control group.

Experts are still trying to understand how head injuries, concussions, and other factors change the brain to cause CTE.Some scientists, such as the VICIS team and the Camarillo lab, believe that reducing the fierceness of the hardest hits that result in isolated concussions through more effective helmets will reduce the number and severity of CTE cases.

In the past decade, the NFL has spent over$200 million on concussion research, with multi-million dollar contributions in 2016 and 2018. However, at least some of that research has been overshadowed by what seems on the surface like a practice of funding labs associated with the NFL while withholding funds from labs that are critical of the organization. Players' lives are at stake and it is beyond time that the multi-billion dollar organizations that run this sport start putting players over profits. New helmet designs may be exciting parts of the solution, but only if the goal remains focused on sparing participants a lifetime of brain damage. In mid-November 2019, the NFL announced a $2 million grant competition to create a new top performing helmet. Let's hope that it will go to unbiased researchers with good intentions.

More:
Helmets protect athletes' skulls. Will the NFL use neuroscience to protect their brains? - Massive Science

Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates – Yahoo Finance

Award Winning Agency Will Help Democratize Neuroscience for Companies Worldwide

Immersion Neuroscience, the worlds most advanced predictive software company unlocking neuroscience to measure what people love, has selected Bob Gold & Associates, a nationally recognized boutique public relations and marketing agency, as its public relations agency of record to help launch its new cloud-based audience prediction platform. The Immersion platform helps companies identify, quantify and predict what live or taped events, training, and entertainment motivate audiences to action so that companies can significantly improve their ability to connect with consumers and increase ROI.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200302005126/en/

"With more than two decades of research, weve developed an entirely new way to understand how the brain values content, and how to predict what content will drive actions with high accuracy," said Paul J. Zak, Ph.D., Founder of Immersion. "We coined the term immersion to denote a measurable neurologic state, and today, Immersion offers an easy to use and powerful tool that allows any company to analyze content and predict how audiences will respond. And it doesn't take a neuroscientist to know that Bob Gold & Associates, with their unparalleled expertise and a proven track record, is the right company to help get our story told."

Immersions proprietary solution and software is the world's most accurate way to measure the brain's unconscious emotional responses to virtually any type of content whether its video, music, live events, training, educational resources and more. Developed by distinguished research scientists, Immersions simple to use and scalable predictive SaaS platform democratizes neuroscience so that anyone can measure what people love at scale.

"Life doesnt happen inside a lab," Zak added. "Until now, companies could only measure what people in the real world said they liked not how their brains were truly valuing an experience. Immersion is able to measure what folks truly, viscerally love, anywhere, anytime and in real time."

The Immersion platform infers when the brain values an experience in real-time with a small wearable sensor that can be used anywhere. Unlike traditional neuroscience technologies that use expensive, immobile and delicate lab equipment and require highly trained professionals to collect and analyze the data, Immersion takes multiple measures of brain activity and puts them into an easy to understand 0-10 measure collected every second. Immersions clients use the platform anywhere, anytime and at scale, empowering companies to predict future behavior and market outcomes with 90% or better accuracy.

"Immersion is a revolutionary company. With their unique cloud-based solution, measuring brain activity is no longer confined to a laboratory with expensive instruments," said Bob Gold, CEO of Bob Gold & Associates. "There are billions of dollars being spent in original programming, half of which never connects with audiences. Today for every network and streaming service, hits are everything. Immersion has proven, with peer-reviewed publications and blinded studies, its ability to identify hit shows, movies, songs and so much more."

Because its built in the cloud, and not in a lab, Immersions software is portable and effortlessly scalable, enabling clients to leverage the power of neuroscience on the fly, anywhere in the world. And while other companies can take months to compile results, Immersions software provides an immediate assessment, unlocking the power of neuroscience for anyone without the need for extensive training.

In one study, for example, two measures from the platform peak immersion, and frustration were enough to predict the top-rated unscripted TV shows with 84% accuracy.

Many leading global brands are already utilizing Immersion in countless ways. This includes shaping content and business decisions by predicting hit TV shows and movies, chart-topping songs, sales bumps, TV ratings, viral content, what has the highest impact at live events, and even HR and corporate training, all by accurately identifying what is truly valued by audience members brains.

For more about Bob Gold & Associates, visit http://www.bobgoldpr.com.

To learn more about Immersion, visit http://www.getimmersion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005126/en/

Contacts

Andrew LaszacsBob Gold & Associates 310-320-2010immersion@bobgoldpr.com

Originally posted here:
Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates - Yahoo Finance